Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.2.713

Does HBV Infection Increase Risk of Endometrial Carcinoma?  

Jiang, Xue-Feng (Department of Obstetrics and Gynecology, the First Affiliated Hospital, Jinan University)
Tang, Qiong-Lan (Department of Pathology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University)
Zou, Yuan (Department of Ultrasound, Affiliated Hospital of North Sichuan Medical College)
Xu, Ling (Department of Pediatrics, Guangzhou Women and Childrens Medical Center)
Zeng, Hua (Department of Clinical Laboratory, Sun Yat-sen Memorial Hospital, Sun Yat-sen University)
Chi, Cong (Department of Obstetrics and Gynecology, the First Affiliated Hospital, Jinan University)
Jiang, Jing-Ru (Department of Obstetrics and Gynecology, the First Affiliated Hospital, Jinan University)
Zhang, Bin-Zhong (Department of Obstetrics and Gynecology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.2, 2014 , pp. 713-716 More about this Journal
Abstract
Objective: Connections between chronic inflammation and tumor development and progression are now generally accepted. Recent evidence indicates that hepatitis B is associated with several types of cancer, but whether endometrial carcinoma (EC) is included has not been reported. Methods: We analyzed HBV serum marker status in 398 patients with endometrial cancer, comparing them to 788 control women undergoing health examination. Results: The total prevalence of HBsAg tested positive in cancer group was significantly higher than the control group (12.8% vs 6.0%, P=0.001), while positive HBsAb was significantly lower (41.2% vs 68.5%, P=0.001). Hepatitis B carriers in endometrial cancer group were also more frequent than in the control group (9.3% vs 5.5%, P=0.013). Interestingly, in the endometrial cancer group, 147 cases were HBV serum marker negative, which was also higher than in the control group (36.9% vs 15.6%, P=0.001). Conclusion: There may be a correlation between HBV infection and endometrial carcinoma.
Keywords
Endometrial carcinoma; hepatitis B; serum markers;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Becker N, Schnitzler P, Boffetta P, et al (2012). Hepatitis B virus infection and risk of lymphoma: results of a serological analysis within the European case-control study Epilymph. J Cancer Res Clin Oncol, 138, 1993-2001.   DOI   ScienceOn
2 King LY, Chung RT (2010). When treating cancer, please don't forget hepatitis B. Oncologist, 15, 826-9.   DOI   ScienceOn
3 Siu SS, Cheung TH, Chan PK, et al (2007). Patients with malignant or pre-malignant cervical lesion have increased risk of becoming hepatitis B carrier. J Exp Clin Cancer Res, 26, 77-81.
4 Sorrell MF, Belongia EA, Costa J, et al (2009). National Institutes of Health Consensus Development Conference statement: Management of hepatitis B. Ann Intern Med, 150, 104-10.   DOI   ScienceOn
5 Campagnoli C, Abba C, Ambroggio S et al (2013). Life-style and metformin for the prevention of endometrial pathology in postmenopausal women. Gynecol Endocrinol, 29, 119-24.   DOI   ScienceOn
6 Jiang XF, Tang QL, Shen XM, et al (2012). Tumor-associated macrophages, epidermal growth factor receptor correlated with the triple negative phenotype in endometrial endometrioid adenocarcinoma. Pathol Res Pract, 208, 730-5.   DOI   ScienceOn
7 Jin Y, Gao H, Chen H, et al (2013). Identification and impact of hepatitis B virus DNA and antigens in pancreatic cancer tissues and adjacent non-cancerous tissues. Cancer Lett, 335, 447-54.   DOI   ScienceOn
8 Liang X, Bi S, Yang W, et al (2009). Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination. Vaccine, 27, 6550-7.   DOI   ScienceOn
9 Liu J, Fan D (2007). Hepatitis B in China. Lancet, 369, 1582-3.   DOI   ScienceOn
10 Mantovani A (2005). Cancer: Inflammation by remote control. Nature, 435, 752-3.   DOI   ScienceOn
11 Mason A (2006). Role of viral replication in extrahepatic syndromes related to hepatitis B virus infection. Minerva Gastroenterol Dietol, 52, 53-66.
12 Mason A, Wick M, White H, et al (1993). Hepatitis B virus replication in diverse cell types during chronic hepatitis B virus infection. Hepatology, 18, 781-9.   DOI   ScienceOn
13 Terrier B, Cacoub P (2011). Hepatitis B virus, extrahepatic immunologic manifestations and risk of viral reactivation. Rev Med Intern, 32, 622-7.   DOI   ScienceOn
14 Ocana S, Casas ML, Buhigas I, et al (2011). Diagnostic strategy for occult hepatitis B virus infection. World J Gastroenterol, 17, 1553-7.   DOI   ScienceOn
15 Park SH, Kim DJ, Lee HY (2009). Insulin resistance is not associated with histologic severity in nondiabetic, noncirrhotic patients with chronic hepatitis B virus infection. Am J Gastroenterol, 104, 1135-39.   DOI   ScienceOn
16 Zur Hausen H (1999). Viruses in Human Cancers. Eur J Cancer, 35, 1174-81.   DOI   ScienceOn
17 Uchida T, Kaneita Y, Gotoh K, et al (1997). Hepatitis C virus is frequently coinfected with serum marker-negative hepatitis B virus: probable replication promotion of the former by the latter as demonstrated by in vitro cotransfection. J Med Virol, 52, 399-405.   DOI
18 Creasman W (2009). Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet, 105, 109.   DOI   ScienceOn
19 Hsu CS, Liu CH, Wang CC, et al (2012). Impact of hepatitis B virus infection on metabolic profiles and modifying factors. J Viral Hepat, 19, e48-57.   DOI   ScienceOn
20 Iavarone M, Colombo M (2013). HBV infection and hepatocellular carcinoma. Clin Liver Dis, 17, 375-97.   DOI   ScienceOn
21 Jiang XF, Tang QL, Li HG, et al (2013). Tumor-associated macrophages correlate with progesterone receptor loss in endometrial endometrioid adenocarcinoma. J Obstet Gynaecol Res, 39, 855-63.   DOI   ScienceOn
22 Yeo W, Chan PK, Hui P et al (2003). Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: A prospective study. J Med Virol, 70, 553-61.   DOI   ScienceOn